Yao Shunyu, Tencent's Chief AI Scientist and former OpenAI researcher, recently stated at a science symposium in Hong Kong that frontier AI models are rapidly entering the field of biology, with capabilities approaching a critical threshold that could cause real-world harm. This is expected to drive new drug development and medical innovation, but may also bring new security challenges, sparking industry concern over biosecurity risks.
